Co-Diagnostics, Inc.Co-Diagnostics, Inc.Co-Diagnostics, Inc.

Co-Diagnostics, Inc.

No trades
See on Supercharts
Market capitalization
‪35.64 M‬USD
−1.18USD
‪−35.33 M‬USD
‪991.47 K‬USD
‪29.58 M‬
Beta (1Y)
1.61

About Co-Diagnostics, Inc.

CEO
Dwight Howard Egan
Headquarters
Salt Lake City
Employees (FY)
155
Founded
2013
ISIN
US1897631057
FIGI
BBG004HTR2D1
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CODX is 1.16 USD — it has increased by 1.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Co-Diagnostics, Inc. stocks are traded under the ticker CODX.
Co-Diagnostics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CODX stock is 8.62% volatile and has beta coefficient of 1.61. Check out the list of the most volatile stocks — is Co-Diagnostics, Inc. there?
One year price forecast for Co-Diagnostics, Inc. has a max estimate of 2.50 USD and a min estimate of 2.50 USD.
CODX earnings for the last quarter are −0.20 USD whereas the estimation was −0.29 USD which accounts for 31.03% surprise. Estimated earnings for the next quarter are −0.20 USD. See more details about Co-Diagnostics, Inc. earnings.
Co-Diagnostics, Inc. revenue for the last quarter amounts to ‪2.46 M‬ USD despite the estimated figure of ‪200.00 K‬ USD. In the next quarter revenue is expected to reach ‪3.63 M‬ USD.
Yes, you can track Co-Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
CODX stock has fallen by 3.33% compared to the previous week, the month change is a 11.54% rise, over the last year Co-Diagnostics, Inc. has showed a 23.68% decrease.
CODX net income for the last quarter is ‪−14.68 M‬ USD, while the quarter before that showed ‪−5.98 M‬ USD of net income which accounts for −145.34% change. Track more Co-Diagnostics, Inc. financial stats to get the full picture.
Today Co-Diagnostics, Inc. has the market capitalization of ‪35.64 M‬, it has increased by 11.93% over the last week.
No, CODX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CODX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Co-Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CODX reached its all-time high on Aug 3, 2020 with the price of 30.99 USD, and its all-time low was 0.69 USD and was reached on Jun 5, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 155.00 employees. See our rating of the largest employees — is Co-Diagnostics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Co-Diagnostics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Co-Diagnostics, Inc. stock shows the sell signal. See more of Co-Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Co-Diagnostics, Inc. future price: according to them, CODX price has a max estimate of 2.50 USD and a min estimate of 2.50 USD. Read a more detailed Co-Diagnostics, Inc. forecast: see what analysts think of Co-Diagnostics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Co-Diagnostics, Inc. EBITDA is ‪−41.45 M‬ USD, and current EBITDA margin is ‪−4.77 K‬%. See more stats in Co-Diagnostics, Inc. financial statements.